| Application no. and date | 10747619.4 (espacenet) (Federated) (European Patent Register), 20100825 | | Patent/reg. no. and date | DK/EP 2470545, 20131009 | | Publication date | 20120704 | | Priority no. and date | US 237435 P, 20090827 | | EP pub. no. and date |
EP 2470545 20120704 | | Effective date | | | Applicant/owner | KaNDy Therapeutics Limited, 400 South Oak Way
Reading, Berkshire RG2 6AD, GB | | Applicant ref. no. | P128525.DK.01/NWH | | Inventor | CRAIG, Andrew, Simon, GlaxoSmithKline
Gunnels Wood Road
Stevenage Hertfordshire SG1 2NY, GB,
ISMAIL, Salima, Zarah, GlaxoSmithKline
Gunnels Wood Road
Stevenage Hertfordshire SG1 2NY, GB,
LAWRENCE, Ronnie, Maxwell, c/o GlaxoSmithKline
Gunnels Wood Road
Stevenage Hertfordshire SG1 2NY, GB | | Representative | MURGITROYD & COMPANY, Mannerheimvägen 12B, 5tr
FI-00100 Helsingfors, FI | | Opponent | | | IPC Class | A61K 31/4985 (2006.01) , A61P 25/00 (2006.01) , C07D 498/04 (2006.01) | | Title | Anhydrate former af et pyridinderivat | | Int. application no. | EP2010062420 | | Int. publication no. | WO2011023733 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
